Pembrolizumab in Advanced Soft Tissue and Bone Sarcomas: Results of SARC028, A Multicentre, Single arm, Phase 2 Trial
Gespeichert in:
Veröffentlicht in: | The lancet oncology 2017-10, Vol.18 (11), p.1493-1501 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1501 |
---|---|
container_issue | 11 |
container_start_page | 1493 |
container_title | The lancet oncology |
container_volume | 18 |
creator | Tawbi, Hussein A. Burgess, Melissa Bolejack, Vanessa Van Tine, Brain A. Schuetze, Scott M. Hu, James D’Angelo, Sandra Attia, Steven Riedel, Richard F. Priebat, Dennis A. Movva, Sujana Davis, Lara E. Okuno, Scott H. Reed, Damon R. Crowley, John Butterfield, Lisa H. Salazar, Ruth Rodriguez-Canales, Jaime Lazar, Alexander J. Wistuba, Ignacio I. Baker, Laurence H. Maki, Robert G. Reinke, Denise Patel, Shreyaskumar |
description | |
doi_str_mv | 10.1016/S1470-2045(17)30624-1 |
format | Article |
fullrecord | <record><control><sourceid>pubmedcentral</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7939029</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_7939029</sourcerecordid><originalsourceid>FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_79390293</originalsourceid><addsrcrecordid>eNqljE1LxDAYhIMo7vrxE4T3qNBqkqZt6kGoi-JFWLa9l7RNdyP5WJJ2QX-9ZfXi2dMMM_MMQjcE3xNMsoeKsBzHFLP0luR3Cc4oi8kJWs4xi1PG-enR_0wW6CKED4xJTnB6jhaUF5xnLFuiaS1N651WX5MRLSgLZX8QtpM9VG4YoVYhTBKE7eHZWQmV8J0zIjzCRoZJjwHcAFW5WWHKIyjhfc5UJ-3oZQSVsls9w95EsN6JIIFC7ZXQV-hsEDrI61-9RE-vL_XqLd5PrZH9kRe62XtlhP9snFDN38aqXbN1hyYvkgLTIvn3wTfzY2mx</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Pembrolizumab in Advanced Soft Tissue and Bone Sarcomas: Results of SARC028, A Multicentre, Single arm, Phase 2 Trial</title><source>Elsevier ScienceDirect Journals Complete</source><creator>Tawbi, Hussein A. ; Burgess, Melissa ; Bolejack, Vanessa ; Van Tine, Brain A. ; Schuetze, Scott M. ; Hu, James ; D’Angelo, Sandra ; Attia, Steven ; Riedel, Richard F. ; Priebat, Dennis A. ; Movva, Sujana ; Davis, Lara E. ; Okuno, Scott H. ; Reed, Damon R. ; Crowley, John ; Butterfield, Lisa H. ; Salazar, Ruth ; Rodriguez-Canales, Jaime ; Lazar, Alexander J. ; Wistuba, Ignacio I. ; Baker, Laurence H. ; Maki, Robert G. ; Reinke, Denise ; Patel, Shreyaskumar</creator><creatorcontrib>Tawbi, Hussein A. ; Burgess, Melissa ; Bolejack, Vanessa ; Van Tine, Brain A. ; Schuetze, Scott M. ; Hu, James ; D’Angelo, Sandra ; Attia, Steven ; Riedel, Richard F. ; Priebat, Dennis A. ; Movva, Sujana ; Davis, Lara E. ; Okuno, Scott H. ; Reed, Damon R. ; Crowley, John ; Butterfield, Lisa H. ; Salazar, Ruth ; Rodriguez-Canales, Jaime ; Lazar, Alexander J. ; Wistuba, Ignacio I. ; Baker, Laurence H. ; Maki, Robert G. ; Reinke, Denise ; Patel, Shreyaskumar</creatorcontrib><identifier>ISSN: 1470-2045</identifier><identifier>EISSN: 1474-5488</identifier><identifier>DOI: 10.1016/S1470-2045(17)30624-1</identifier><identifier>PMID: 28988646</identifier><language>eng</language><ispartof>The lancet oncology, 2017-10, Vol.18 (11), p.1493-1501</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids></links><search><creatorcontrib>Tawbi, Hussein A.</creatorcontrib><creatorcontrib>Burgess, Melissa</creatorcontrib><creatorcontrib>Bolejack, Vanessa</creatorcontrib><creatorcontrib>Van Tine, Brain A.</creatorcontrib><creatorcontrib>Schuetze, Scott M.</creatorcontrib><creatorcontrib>Hu, James</creatorcontrib><creatorcontrib>D’Angelo, Sandra</creatorcontrib><creatorcontrib>Attia, Steven</creatorcontrib><creatorcontrib>Riedel, Richard F.</creatorcontrib><creatorcontrib>Priebat, Dennis A.</creatorcontrib><creatorcontrib>Movva, Sujana</creatorcontrib><creatorcontrib>Davis, Lara E.</creatorcontrib><creatorcontrib>Okuno, Scott H.</creatorcontrib><creatorcontrib>Reed, Damon R.</creatorcontrib><creatorcontrib>Crowley, John</creatorcontrib><creatorcontrib>Butterfield, Lisa H.</creatorcontrib><creatorcontrib>Salazar, Ruth</creatorcontrib><creatorcontrib>Rodriguez-Canales, Jaime</creatorcontrib><creatorcontrib>Lazar, Alexander J.</creatorcontrib><creatorcontrib>Wistuba, Ignacio I.</creatorcontrib><creatorcontrib>Baker, Laurence H.</creatorcontrib><creatorcontrib>Maki, Robert G.</creatorcontrib><creatorcontrib>Reinke, Denise</creatorcontrib><creatorcontrib>Patel, Shreyaskumar</creatorcontrib><title>Pembrolizumab in Advanced Soft Tissue and Bone Sarcomas: Results of SARC028, A Multicentre, Single arm, Phase 2 Trial</title><title>The lancet oncology</title><issn>1470-2045</issn><issn>1474-5488</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNqljE1LxDAYhIMo7vrxE4T3qNBqkqZt6kGoi-JFWLa9l7RNdyP5WJJ2QX-9ZfXi2dMMM_MMQjcE3xNMsoeKsBzHFLP0luR3Cc4oi8kJWs4xi1PG-enR_0wW6CKED4xJTnB6jhaUF5xnLFuiaS1N651WX5MRLSgLZX8QtpM9VG4YoVYhTBKE7eHZWQmV8J0zIjzCRoZJjwHcAFW5WWHKIyjhfc5UJ-3oZQSVsls9w95EsN6JIIFC7ZXQV-hsEDrI61-9RE-vL_XqLd5PrZH9kRe62XtlhP9snFDN38aqXbN1hyYvkgLTIvn3wTfzY2mx</recordid><startdate>20171004</startdate><enddate>20171004</enddate><creator>Tawbi, Hussein A.</creator><creator>Burgess, Melissa</creator><creator>Bolejack, Vanessa</creator><creator>Van Tine, Brain A.</creator><creator>Schuetze, Scott M.</creator><creator>Hu, James</creator><creator>D’Angelo, Sandra</creator><creator>Attia, Steven</creator><creator>Riedel, Richard F.</creator><creator>Priebat, Dennis A.</creator><creator>Movva, Sujana</creator><creator>Davis, Lara E.</creator><creator>Okuno, Scott H.</creator><creator>Reed, Damon R.</creator><creator>Crowley, John</creator><creator>Butterfield, Lisa H.</creator><creator>Salazar, Ruth</creator><creator>Rodriguez-Canales, Jaime</creator><creator>Lazar, Alexander J.</creator><creator>Wistuba, Ignacio I.</creator><creator>Baker, Laurence H.</creator><creator>Maki, Robert G.</creator><creator>Reinke, Denise</creator><creator>Patel, Shreyaskumar</creator><scope>5PM</scope></search><sort><creationdate>20171004</creationdate><title>Pembrolizumab in Advanced Soft Tissue and Bone Sarcomas: Results of SARC028, A Multicentre, Single arm, Phase 2 Trial</title><author>Tawbi, Hussein A. ; Burgess, Melissa ; Bolejack, Vanessa ; Van Tine, Brain A. ; Schuetze, Scott M. ; Hu, James ; D’Angelo, Sandra ; Attia, Steven ; Riedel, Richard F. ; Priebat, Dennis A. ; Movva, Sujana ; Davis, Lara E. ; Okuno, Scott H. ; Reed, Damon R. ; Crowley, John ; Butterfield, Lisa H. ; Salazar, Ruth ; Rodriguez-Canales, Jaime ; Lazar, Alexander J. ; Wistuba, Ignacio I. ; Baker, Laurence H. ; Maki, Robert G. ; Reinke, Denise ; Patel, Shreyaskumar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_79390293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tawbi, Hussein A.</creatorcontrib><creatorcontrib>Burgess, Melissa</creatorcontrib><creatorcontrib>Bolejack, Vanessa</creatorcontrib><creatorcontrib>Van Tine, Brain A.</creatorcontrib><creatorcontrib>Schuetze, Scott M.</creatorcontrib><creatorcontrib>Hu, James</creatorcontrib><creatorcontrib>D’Angelo, Sandra</creatorcontrib><creatorcontrib>Attia, Steven</creatorcontrib><creatorcontrib>Riedel, Richard F.</creatorcontrib><creatorcontrib>Priebat, Dennis A.</creatorcontrib><creatorcontrib>Movva, Sujana</creatorcontrib><creatorcontrib>Davis, Lara E.</creatorcontrib><creatorcontrib>Okuno, Scott H.</creatorcontrib><creatorcontrib>Reed, Damon R.</creatorcontrib><creatorcontrib>Crowley, John</creatorcontrib><creatorcontrib>Butterfield, Lisa H.</creatorcontrib><creatorcontrib>Salazar, Ruth</creatorcontrib><creatorcontrib>Rodriguez-Canales, Jaime</creatorcontrib><creatorcontrib>Lazar, Alexander J.</creatorcontrib><creatorcontrib>Wistuba, Ignacio I.</creatorcontrib><creatorcontrib>Baker, Laurence H.</creatorcontrib><creatorcontrib>Maki, Robert G.</creatorcontrib><creatorcontrib>Reinke, Denise</creatorcontrib><creatorcontrib>Patel, Shreyaskumar</creatorcontrib><collection>PubMed Central (Full Participant titles)</collection><jtitle>The lancet oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tawbi, Hussein A.</au><au>Burgess, Melissa</au><au>Bolejack, Vanessa</au><au>Van Tine, Brain A.</au><au>Schuetze, Scott M.</au><au>Hu, James</au><au>D’Angelo, Sandra</au><au>Attia, Steven</au><au>Riedel, Richard F.</au><au>Priebat, Dennis A.</au><au>Movva, Sujana</au><au>Davis, Lara E.</au><au>Okuno, Scott H.</au><au>Reed, Damon R.</au><au>Crowley, John</au><au>Butterfield, Lisa H.</au><au>Salazar, Ruth</au><au>Rodriguez-Canales, Jaime</au><au>Lazar, Alexander J.</au><au>Wistuba, Ignacio I.</au><au>Baker, Laurence H.</au><au>Maki, Robert G.</au><au>Reinke, Denise</au><au>Patel, Shreyaskumar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pembrolizumab in Advanced Soft Tissue and Bone Sarcomas: Results of SARC028, A Multicentre, Single arm, Phase 2 Trial</atitle><jtitle>The lancet oncology</jtitle><date>2017-10-04</date><risdate>2017</risdate><volume>18</volume><issue>11</issue><spage>1493</spage><epage>1501</epage><pages>1493-1501</pages><issn>1470-2045</issn><eissn>1474-5488</eissn><pmid>28988646</pmid><doi>10.1016/S1470-2045(17)30624-1</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1470-2045 |
ispartof | The lancet oncology, 2017-10, Vol.18 (11), p.1493-1501 |
issn | 1470-2045 1474-5488 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7939029 |
source | Elsevier ScienceDirect Journals Complete |
title | Pembrolizumab in Advanced Soft Tissue and Bone Sarcomas: Results of SARC028, A Multicentre, Single arm, Phase 2 Trial |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T07%3A53%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pembrolizumab%20in%20Advanced%20Soft%20Tissue%20and%20Bone%20Sarcomas:%20Results%20of%20SARC028,%20A%20Multicentre,%20Single%20arm,%20Phase%202%20Trial&rft.jtitle=The%20lancet%20oncology&rft.au=Tawbi,%20Hussein%20A.&rft.date=2017-10-04&rft.volume=18&rft.issue=11&rft.spage=1493&rft.epage=1501&rft.pages=1493-1501&rft.issn=1470-2045&rft.eissn=1474-5488&rft_id=info:doi/10.1016/S1470-2045(17)30624-1&rft_dat=%3Cpubmedcentral%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_7939029%3C/pubmedcentral%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/28988646&rfr_iscdi=true |